[
  {
    "ts": null,
    "headline": "Where is Incyte Corporation (INCY) Headed According to Analysts?",
    "summary": "Incyte Corporation (NASDAQ:INCY) is one of the best immunotherapy stocks to buy according to hedge funds. Jefferies reiterated a Buy rating on Incyte Corporation (NASDAQ:INCY) on February 11, setting a price target of $120. The same day, Morgan Stanley also lifted the price target on the stock to $102 from $94 while maintaining an Equal […]",
    "url": "https://finnhub.io/api/news?id=be628c41dae15465eef6fe5fc143dc2de7bc0cd40d5016db3bf09fca8727f93d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771512958,
      "headline": "Where is Incyte Corporation (INCY) Headed According to Analysts?",
      "id": 139149306,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Incyte Corporation (NASDAQ:INCY) is one of the best immunotherapy stocks to buy according to hedge funds. Jefferies reiterated a Buy rating on Incyte Corporation (NASDAQ:INCY) on February 11, setting a price target of $120. The same day, Morgan Stanley also lifted the price target on the stock to $102 from $94 while maintaining an Equal […]",
      "url": "https://finnhub.io/api/news?id=be628c41dae15465eef6fe5fc143dc2de7bc0cd40d5016db3bf09fca8727f93d"
    }
  },
  {
    "ts": null,
    "headline": "1 Unpopular Stock That Deserves a Second Chance and 2 We Question",
    "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
    "url": "https://finnhub.io/api/news?id=4b726a90fc14b5d3f65ebd23375a6d424907741b36e104007355e206dceb2d35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771475985,
      "headline": "1 Unpopular Stock That Deserves a Second Chance and 2 We Question",
      "id": 139153610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
      "url": "https://finnhub.io/api/news?id=4b726a90fc14b5d3f65ebd23375a6d424907741b36e104007355e206dceb2d35"
    }
  }
]